Head of Communication and Public Affairs
Email: dz@mva.org
Phone: (M) +45 2498 1668
Linkedin
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
The action plan points to three specific focus areas which must be strengthened to further develop Swedish life science. The focus areas are, R&D, the introduction of new innovative treatments and the attractiveness of Sweden for life science related foreign
At Medicon Valley Alliance we have high hopes for the spring! Read which and why in the latest business column “The Valley of Life: A national life science strategy, and the promise of spring” by our Chairman of the Board,
The Berlin-based biotech online media Labiotech.eu, has literally mapped European biotech companies. Their selection criteria is biotech companies with >€1M raised/generated and own innovative technology. Their map is probably the best map to find European biotech’s, and as you can
CEO, Petter Hartman, Morten Sommer, Ulf G. Andersson and Søren Bregenholt At the Medicon Valley Alliance´s Ordinary General Meeting 10th of April, Ulf G Andersson, CEO of Medeon Science Park & Incubator, Malmö was elected new vice-chairman of Medicon Valley Alliance. He
“Life science växer över sundet” is the title of the recently published in-depth article in Swedish “Naturvetaren” about the many benefits of Medicon Valley collaboration. If you are familiar with the Swedish language, we will encourage you to read it.
Medicon Valley Alliance has assisted the editors of Nature, the acknowledged international journal of science, with their recently published special edition “Spotlight on Sweden and Medicon Valley“. Among the articles, we specially recommend “How a bridge brought science closer together” featuring
Which biotech venture capital firms in Europe have been most active in the past year and are likely to protagonize some of the biggest deals in European biotech in 2018? Where are they located? How do we open their eyes
The Medicon Valley Yearbook 2018 has just been published. The Medicon Valley Alliance Chairman of the Board of Directors, Søren Bregenholt, Corporate Vice President, Global Research Strategy and Operations, Novo Nordisk, has used the editorial to strongly recommend that Danish
The four scientists are Bart De Strooper from Belgium, Michel Goedert from Luxembourg, Christian Haass from Germany and John Hardy from the UK. They are recognised for their highly specialised studies of Alzheimer’s disease and other dementia disorders and are